For subjects with CABP-associated bacteremia , clinical response/cure rates were similar at Day 4 ( 60.9 % vs 59.1 % ) , end of therapy ( 69.6 % vs 72.7 % ) , and test of cure ( 69.6 % vs 68.2 % ) for ceftaroline fosamil and ceftriaxone , respectively .